Results 71 to 80 of about 2,971 (159)
Role of Serum Tumor Markers in Prognosis of Operable Non-small Cell Lung Cancer Patients
Zhongliu Fangzhi Yanjiu, 2018 Objective To evaluate the prognostic value of CEA, CA125, CA199, NSE, CYFRA21-1 and SCC-Ag as serum tumor markers on the diagnosis of operable non-small cell lung cancer(NSCLC) after radical operation.
LI Shaolei +5 more
doaj +1 more source
Cancer Biology & Medicine, 2012 Objective The aim of this study was to test whether carcinoembryonic antigen (CEA) and cytokeratin 19 fragments (CYFRA21-1) can be used as a prognostic factor for non-small-cell lung cancer (NSCLC) after two cycles of adjuvant chemotherapy in NSCLC ...
Xue-feng Lin +4 more
doaj +1 more source
CYFRA21-1、Pentraxin-3、ProGRP对非小细胞肺癌的诊断价值
Zhongguo shiyan zhenduanxue, 2016 目的探讨细胞角蛋白片段19（CYFRA21-1）、血清穿透素-3（Pentraxin-3）、胃泌素释放肽前体（ProGRP）在非小细胞肺癌（NSCLC）中的应用价值。方法 2013年10月至2014年10月选取62例NSCLC患者、62例肺部良性疾病组及60例健康对照者,采用ELISA法测定三组血清Pentraxin-3、CYFRA21-1、ProGRP水平,采用受试者特异曲线（ROC）评价血清Pentraxin-3、CYFRA21-1、ProGRP在早期NSCLC患者中的应用价值。结果 ...
芦珂
doaj
Retracted: Impact of HSP90α, CEA, NSE, SCC, and CYFRA21-1 on Lung Cancer Patients. [PDF]
J Healthc Eng, 2023 Healthcare Engineering JO.
europepmc +1 more source
Serum Tumor Marker CYFRA21-1 in the Diagnostics of NSCLC Lung Cancer
Collegium antropologicum, 1998 Cytokeratins are epithelial markers whose expression is not lost during malignant transformation. The level of soluble cytokeratin fragment 19 was measured with an enzyme immunoassay method developed by Boehringer Mannheim (Enzymum-test CYFRA 21-1) in the serum of 200 male and 50 female patients with NSCLC (Non Small Cell Lung Cancer) lung cancer (120 ...
Peričić Salihović, Marijana +2 more
openaire
Research in Pharmaceutical SciencesBackground and purpose: Breast cancer is a major global concern, especially because of high mortality linked to advanced stages. Metastasis may occur early, but current diagnostics struggle to detect small metastatic cells.
Zohreh Salimi +3 more
doaj +1 more source
流式荧光发光法联合检测肺癌患者血清CEA、CYFRA21-1、CA125及NSE的性能评价
Zhongguo shiyan zhenduanxue, 2019 目的探讨流式荧光发光法(FFA)对肺癌患者血清中癌胚抗原(CEA)、细胞角蛋白19片段(CYFRA21-1)、癌胚抗原125(CA125)及神经元特异性烯醇化酶(NSE)检测的应用价值。方法用FFA法检测CEA、CYFRA21-1、CA125及NSE的精密度,确定流式荧光发光法(FFA)与电化学发光免疫分析法(ECLIA)检测4种标志物结果的相关性,验证FFA法的准确度及确定4种肿瘤标志物检测的检出限参考区间。对FFA法检测CEA、CYFRA21-1、CA125及NSE的准确性进行评价。结果 ...
赵虹, 纪秋野, 王博扬
doaj
Retracted: Diagnostic Value of FTO Combined with CEA or CYFRA21-1 in Nonsmall Cell Lung Cancer. [PDF]
Evid Based Complement Alternat Med, 2023 And Alternative Medicine EC.
europepmc +1 more source
Retracted: The Role of Change Rates of CYFRA21-1 and CEA in Predicting Chemotherapy Efficacy for Non-Small-Cell Lung Cancer. [PDF]
Comput Math Methods Med, 2023 Methods In Medicine CAM.
europepmc +1 more source
Retracted: Clinical Value of Pleural Effusion and Serum MMP-3 and CYFRA21-1 Combined with ADA in Differential Diagnosis of Pleural Exudative Effusion. [PDF]
Emerg Med Int, 2023 International EM.
europepmc +1 more source